Zobrazeno 1 - 10
of 143
pro vyhledávání: '"Renato G, Martins"'
Autor:
Cassie Pan, Qian Vicky Wu, Jenna Voutsinas, Jeffrey J. Houlton, Brittany Barber, Zain H. Rizvi, Emily Marchiano, Neal Futran, George E. Laramore, Jay J. Liao, Upendra Parvathaneni, Renato G. Martins, Jonathan R. Fromm, Cristina P. Rodriguez
Publikováno v:
Cancer Medicine, Vol 12, Iss 8, Pp 9384-9391 (2023)
Abstract Background Little is known regarding associations between peripheral blood biomarkers (PBBMs) and survival, response, and toxicity in recurrent/metastatic head and neck squamous cell carcinomas (R/M HNSCC) treated with immune checkpoint inhi
Externí odkaz:
https://doaj.org/article/abf9f7ebd9ed41ab997ecff27e40bfec
Autor:
Cameron Chalker, Jenna M. Voutsinas, Qian Vicky Wu, Rafael Santana‐Davila, Victoria Hwang, Christina S. Baik, Sylvia Lee, Brittany Barber, Neal D. Futran, Jeffrey J. Houlton, George E. Laramore, Jay Justin Liao, Upendra Parvathaneni, Renato G. Martins, Keith D. Eaton, Cristina P. Rodriguez
Publikováno v:
Cancer Medicine, Vol 11, Iss 22, Pp 4104-4111 (2022)
Abstract Background Anti‐PD1 checkpoint inhibitors (ICI) represent an established standard‐of‐care for patients with recurrent/metastatic head and neck squamous cell carcinoma (RMHNSCC). Landmark studies excluded patients with ECOG performance
Externí odkaz:
https://doaj.org/article/53da6a9d3e554131937be881d3ebe09e
Autor:
Stephen R. Bowen, PhD, Daniel S. Hippe, MS, Hannah M. Thomas, PhD, Balukrishna Sasidharan, MBBS, MD, DNB, DMRT, Paul D. Lampe, PhD, Christina S. Baik, MD, MPH, Keith D. Eaton, MD, PhD, Sylvia Lee, MD, Renato G. Martins, MD, MPH, Rafael Santana-Davila, MD, Delphine L. Chen, MD, Paul E. Kinahan, PhD, Robert S. Miyaoka, PhD, Hubert J. Vesselle, MD, PhD, A. McGarry Houghton, MD, Ramesh Rengan, MD, PhD, Jing Zeng, MD
Publikováno v:
Advances in Radiation Oncology, Vol 7, Iss 2, Pp 100857- (2022)
Purpose: We sought to examine the prognostic value of fluorodeoxyglucose-positron emission tomography (PET) imaging during chemoradiation for unresectable non-small cell lung cancer for survival and hypothesized that tumor PET response is correlated
Externí odkaz:
https://doaj.org/article/3fb66f4cd14d4b90978539f30c9d469e
Autor:
Perrin E. Romine, Renato G. Martins, Keith D. Eaton, Douglas E. Wood, Fatemeh Behnia, Bernardo H. L. Goulart, Michael S. Mulligan, Sarah G. Wallace, Elizabeth Kell, Julie E. Bauman, Shilpen A. Patel, Hubert J. Vesselle
Publikováno v:
BMC Cancer, Vol 19, Iss 1, Pp 1-9 (2019)
Abstract Background Neoadjuvant chemotherapy is effective in improving survival of resectable NSCLC. Based on findings in the adjuvant and metastatic setting, FDG positron emission tomography (PET) scans may offer early prognostic or predictive value
Externí odkaz:
https://doaj.org/article/0b333ebbba4a47c1b41710fc169460fd
Autor:
Perrin E. Romine, Qin Sun, Catherine Fedorenko, Li Li, Mariel Tang, Keith D. Eaton, Bernardo H.L. Goulart, Renato G. Martins
Publikováno v:
JCO Oncol Pract
PURPOSE: Time from diagnosis to treatment has been associated with worse survival outcomes in non–small-cell lung cancer (NSCLC). However, little is known about the impact of delay in time to diagnosis. We aimed to evaluate the impact of time from
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6ac4665c2494add52f952f81a115c429
https://doi.org/10.1200/op.21.00485
https://doi.org/10.1200/op.21.00485
Autor:
Steven I. Sherman, James P. O'Brien, Min Ren, Yasuhiro Funahashi, Lynn Burmeister, Rossella Elisei, Donald Bodenner, Manisha H. Shah, Lisa F. Licitra, Renato G. Martins, Roger Allison, Kate Newbold, Judith McCaffrey, Douglas W. Ball, Furio Pacini, Bruce Robinson, Maria E. Cabanillas, Barbara Jarzab, Martin Schlumberger
Purpose: Positive results of phase I studies evaluating lenvatinib in solid tumors, including thyroid cancer, prompted a phase II trial in advanced medullary thyroid carcinoma (MTC).Experimental Design: Fifty-nine patients with unresectable progressi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::56e5ed6f18d81a0510c811d14bb5c2a6
https://doi.org/10.1158/1078-0432.c.6524540.v1
https://doi.org/10.1158/1078-0432.c.6524540.v1
Autor:
Steven I. Sherman, James P. O'Brien, Min Ren, Yasuhiro Funahashi, Lynn Burmeister, Rossella Elisei, Donald Bodenner, Manisha H. Shah, Lisa F. Licitra, Renato G. Martins, Roger Allison, Kate Newbold, Judith McCaffrey, Douglas W. Ball, Furio Pacini, Bruce Robinson, Maria E. Cabanillas, Barbara Jarzab, Martin Schlumberger
Tumor response
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::424f5a14fa1207ff7bfc2d2330c29134
https://doi.org/10.1158/1078-0432.22460585
https://doi.org/10.1158/1078-0432.22460585
Autor:
Cristina Merkhofer, Renato G. Martins, Scott D. Ramsey, Keith D. Eaton, Bernardo H. L. Goulart
Publikováno v:
Clin Lung Cancer
Introduction The impact of clinical trial participation on overall survival is unclear. We hypothesized that enrollment in a therapeutic drug clinical trial is associated with longer overall survival in patients with metastatic non-small cell lung ca
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::006378c6a23f446188c07c402ad14970
https://doi.org/10.1016/j.cllc.2021.04.003
https://doi.org/10.1016/j.cllc.2021.04.003
Autor:
Renato G. Martins, Cristina Merkhofer, Bernardo H. L. Goulart, Keith D. Eaton, Shasank Chennupati, Scott D. Ramsey, Qin Sun
Publikováno v:
JCO Oncol Pract
PURPOSE: The costs associated with clinical trial enrollment remain uncertain. We hypothesized that trial participation is associated with decreased total direct medical costs to health care payers in metastatic non–small-cell lung cancer. METHODS:
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d9fdfe54a58686651741faadadbcc141
https://doi.org/10.1200/op.20.01092
https://doi.org/10.1200/op.20.01092
Autor:
Amita Patnaik, Matthew A. Gubens, Shirish M. Gadgeel, James P. Stevenson, Bilal Piperdi, Ryan D. Gentzler, Mark M. Awad, Shadia I. Jalal, Mehmet Altan, Lecia V. Sequist, Amit Panwalkar, Bin Zhao, James Chih-Hsin Yang, Sanatan Saraf, Hossein Borghaei, Steven Francis Powell, Renato G. Martins, Corey J. Langer
Publikováno v:
Journal of Thoracic Oncology. 16:162-168
Introduction In cohort G of KEYNOTE-021 (NCT02039674), first-line pembrolizumab plus pemetrexed-carboplatin significantly improved the objective response rate and progression-free survival versus chemotherapy alone with manageable toxicity in advance
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3cfcf24c97ea524d6ee05ebef4f83c41
https://doi.org/10.1016/j.jtho.2020.09.015
https://doi.org/10.1016/j.jtho.2020.09.015